to it, axons are myelinated by Schwann cells and the supporting tissue is endoneurium. Central to it, oligodendrocytes form the myelin sheaths, and fibres are separated to a variable degree by astrocytic tissue.
It has long been recognised that dorsal and ventral root TZ Schwann cells may, in certain situations, migrate into the spinal cord, especially in response to cord injury [16, 17, 28] . The role of Schwann cells in the CNS is unclear, but it has been suggested that their presence may impede regeneration following spinal cord injury [8] . Conversely, other studies have used PNS grafts to support axonal elongation across transection lesions in adult rat spinal cord [6, 21] . It has been shown that Schwann cell populations, when grafted into the injured spinal cord, subsequently ensheath the regenerating axons entering the graft [26] . Furthermore, Schwann cells possess a basal lamina, which contains extracellular matrix molecules that promote nerve fibre growth [1] .
In tissue sections the invading Schwann cells are easily recognised as tumourlets. Rarely, these clusters of invading Schwann cells may enlarge and become indistinguishable from a schwannoma. Similar Schwann cell invasion may be present in patients with neurofibromatosis [23] . On the other hand, glial cells have been detected in the PNS, particularly in the ventral roots, as islands of cells [11] .
The following case report serves to further highlight the fact that the TZ is not an impenetrable barrier, but one that can in certain conditions be breached by Schwann cells. Manipulation of this barrier to aid Schwann cell invasion of the injured or demyelinated cord offers a possible future therapeutic strategy. This report underlines the close relationship between basic and clinical neuroscience as well as the potential for these together to address the central clinical problems.
Case report
A 48-year-old man presented with a 6-month history of bilateral lower extremity weakness affecting the right side more than the left. Numbness was present along inner and outer aspects of the Magnetic resonance imaging (MRI) of the entire neuraxis revealed an intramedullary tumour extending from the conus medullaris at the lower border of L1 to the upper border of T11 (Fig. 2a,b) .
At operation, image intensification was used to localize the T11, T12 and L1 vertebral levels. A three-level laminectomy was performed to expose the T11, T12 and L1 regions. A midline durotomy revealed a diffusely swollen spinal cord. Under the operating microscope, a tumour was clearly seen arising from the right-sided nerve roots of the cauda equina at the lower border of L1. The tumour invaded the conus medullaris as well as the right side and centre of the cord above it. An intra-operative frozen section report suggested a schwannoma. A dorsal midline myelotomy was used to expose the tumour, which was fully excised using sharp microscopic dissection and a micro-ultrasonic aspirator. A full macroscopic excision of the tumour was achieved. The patient made an uneventful recovery from surgery and was without neurological deficit. A 6-months post-operative MR image of the spine shows no evidence of recurrent tumour (Fig. 2c) .
Histological examination of the resected tumour revealed a densely cellular non-glial derived neoplasm in which cells were large with plump spindle-shaped nuclei and long tapering cytoplasmic processes (Fig. 3a,b) . Cells were arranged into ill-defined interwoven fascicles. Rare verocay-like bodies were present. There was no evidence of tumour necrosis and mitotic figures were not present. Immunohistochemistry was negative for glial fibrillary acidic protein, but S-100 was positive. The features were those of a schwannoma.
Discussion
Spinal intramedullary schwannomas have been described both in association with and independent of neurofibromatosis [4, 5, 7, 10, 23, 24] . They have been estimated to represent 0.3% of all intraspinal tumours. A recent review of the MRI findings of 14 intramedullary spinal schwannomas showed that the lower thoracic spinal cord is amongst the least common sites for their occurrence [27] . Subtotal excision leads to recurrence, and the importance of accurate intra-operative frozen section reports is emphasized in order to attempt a full tumour clearance [7] .
Clusters of cells are found on developing ventral rootlets [13, 14] . These may act as a pluripotential source of cells. Some of these differentiate into Schwann cells, which ensheath and myelinate axons of the ventral rootlets. There is evidence that others leave the clusters but fail to ensheath axons. These ectopic Schwann cells have each their own covering of basal lamina. They come to lie in the rootlet endoneurium or in the adjacent pia mater, close to the CNS-PNS interface (Fraher and Kaar, unpublished). There are corresponding clusters at the dorsal rootlet transitional zone (DRTZ) [9, 13, 18, 19, 20] . These form boundary caps. There is evidence to suggest that these may influence the entry of dorsal root axons into the early spinal cord. Their eventual fate in dorsal rootlets is unclear. However, it may be that the clusters disaggregate here too, and give rise to Schwann cells [15] . It is therefore possible that, as at ventral rootlets, some of them fail to enfold dorsal rootlet axons. Neoplastic proliferation of such cells is a possible source of tumours at TZs, including that of cranial nerve VIII, where they could give rise to acoustic neuromas, as well as at the DRTZ. They could therefore arise from Schwann cells with an ectopic pial location. Such a location for them is suggested by the finding that the pia mater also stains with nerve growth factor receptor, an embryonic Schwann cell marker [29] .
Invasion of the cord by such neoplasms would entail their growth centrally through the dorsal rootlets as far as the CNS-PNS interface. On reaching this, the tumour cells could displace the CNS tissue and invaginate it centrally, through the rootlet and then into the cord itself. Alternatively, the Schwann cells could intermingle with CNS tissue. This would involve their penetration of the CNS-PNS interface. A series of immunohistochemical observations has shown an intense staining of the glia limitans, with nerve cell adhesion factor (NCAM), [25] . It is possible that Schwann cell tumour cells could achieve penetration by secreting factors that denature NCAM at the glia limitans and allow tumour penetration of the TZ.
The tumour could also have arisen from ectopic Schwann cells within the CNS. These are not uncommon and their numbers increase with age. They could have been derived from Schwann cells of perivascular nerve bundles. The paucity of blood vessels in the DRTZ region perhaps argues against this [2, 3] . However, they could also arise as a result of interruption of the glia limitans associated with minor traumata of the TZ, perhaps associated with mild repeated traction injuries of the roots.
Irradiation of the spinal cord creates a glial deficient spinal cord. This is associated with Schwann cell invasion of the cord as the glia limitans loses its constituent cells [16, 28] . It has been shown that dorsal root axons can regrow into such an environment [28] . It is interesting to speculate on the potential for radiosurgery to precisely create such an environment in humans. Further work on the immunohistochemistry of the TZ and its response to antibody application is indicated.
Conclusion
The perception that Schwann cells are never present in the CNS is false. This case report illustrates an intramedullary schwannoma of the thoracic spinal cord. Manipulation of the transitional zone astrocytic barrier at both cranial and spinal levels may in future provide a therapeutic strategy to aid remyelination in various pathological conditions of the CNS.
